The Anti-inflammatory Effect of Gigukjiwhangwhangami through the Inhibition of Nuclear Factor-κB Activation in the Peripheral Blood Mononuclear Cells of Patients with Cerebral Infarction
-
- Kim Su-Jin
- College of Oriental Medicine, Institute of Oriental Medicine, Kyung Hee University College of Pharmacy, Wonkwang University
-
- Jeong Hyun-Ja
- College of Oriental Medicine, Institute of Oriental Medicine, Kyung Hee University
-
- Moon Phil-Dong
- College of Oriental Medicine, Institute of Oriental Medicine, Kyung Hee University
-
- Lee Kang-Min
- Division of Biological Sciences, College of Natural Science, Chonbuk National University
-
- Lee Min-Gu
- Professional Graduate School of Oriental Medicine, Wonkwang University
-
- Moon Byung-Soon
- Professional Graduate School of Oriental Medicine, Wonkwang University
-
- An Nyeon-Hyoung
- College of Pharmacy, Wonkwang University
-
- Hong Seung-Heon
- College of Pharmacy, Wonkwang University
-
- Na Ho-Jeong
- College of Pharmacy, Woosuk University
-
- Jeon Hoon
- College of Pharmacy, Woosuk University
-
- Kim Hyung-Min
- College of Oriental Medicine, Institute of Oriental Medicine, Kyung Hee University
-
- Um Jae-Young
- College of Oriental Medicine, Institute of Oriental Medicine, Kyung Hee University
書誌事項
- タイトル別名
-
- The Anti-inflammatory Effect of Gigukjiwhangwhangami through the Inhibition of Nuclear Factor-.KAPPA.B Activation in the Peripheral Blood Mononuclear Cells of Patients with Cerebral Infarction
- Anti inflammatory Effect of Gigukjiwhangwhangami through the Inhibition of Nuclear Factor カッパ B Activation in the Peripheral Blood Mononuclear Cells of Patients with Cerebral Infarction
この論文をさがす
抄録
The Korean genuine medicine “Gigukjiwhangwhangami (GJWGM)” has long been used for various cerebrovascular diseases. However, the exact mechanism that accounts for the anti-inflammatory effect of GJWGM is not completely understood. The aim of the present study is to elucidate how GJWGM modulates the inflammatory reaction in lipopolysaccaride (LPS)-stimulated peripheral mononuclear cells from patients with cerebral infarction. Production of cytokine was measured by the ELISA and RT-PCR method. The level of nuclear factor-kappaB (NF-κB)/Rel A protein and NF-κB DNA binding activity were determined by the Western blot analysis and TF-EIA method. We showed that GJWGM inhibited the production of tumor necrosis factor (TNF)-α, interleukin (IL)-1α, IL-6, and IL-8 induced by LPS in dose dependent manner (p<0.05). Maximal inhibition rate of TNF-α, IL-1β, IL-6 and IL-8 production by GJWGM was about 54.34%, 41.37%, 44.04%, and 54.46%, respectively. GJWGM inhibited the TNF-α and IL-8 mRNA expression. In addition, we showed that the inhibitory mechanism of GJWGM is through the suppression of NF-κB pathway. Our study suggests that an important molecular mechanism by GJWGM reduce inflammation, which may explain its beneficial effect in the regulation of inflammatory reactions.
収録刊行物
-
- Biological & Pharmaceutical Bulletin
-
Biological & Pharmaceutical Bulletin 29 (11), 2251-2255, 2006
公益社団法人 日本薬学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390282679604548608
-
- NII論文ID
- 110004840400
-
- NII書誌ID
- AA10885497
-
- ISSN
- 13475215
- 09186158
-
- NDL書誌ID
- 8516213
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- NDL
- Crossref
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可